Browsing byAuthorMehta, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 52 to 71 of 94< previous   next >
Issue DateTitleAuthor(s)
2023-11-08Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development.Mehta, M; Bui, TA; Yang, X; Aksoy, Y; Goldys, EM; Deng, W
2020-04-28MicroRNAs as Biomarker for Breast Cancer.Aggarwal, T; Wadhwa, R; Gupta, R; Paudel, KR; Collet, T; Chellapan, DK; Gupta, G; Perumalsamy, H; Mehta, M; Satija, S; Hansbro, PM; Dua, K; Maurya, PK
-miRNA nanotherapeutics: potential and challenges in respiratory disordersMehta, M; Chellappan, DK; Wich, PR; Hansbro, NG; Hansbro, PM; Dua, K
2020-04Molecular mechanisms of action of naringenin in chronic airway diseasesChin, LH; Hon, CM; Chellappan, DK; Chellian, J; Madheswaran, T; Zeeshan, F; Awasthi, R; Aljabali, AAA; Tambuwala, MM; Dureja, H; Negi, P; Kapoor, DN; Goyal, R; Paudel, KR; Satija, S; Gupta, G; Hsu, A; Wark, P; Mehta, M; Wadhwa, R; Hansbro, PM; Dua, K
2018-11-01Multi-drug resistant Mycobacterium tuberculosis &amp; oxidative stress complexity: Emerging need for novel drug delivery approachesDua, K; Rapalli, VK; Shukla, SD; Singhvi, G; Shastri, MD; Chellappan, DK; Satija, S; Mehta, M; Gulati, M; Pinto, TDJA; Gupta, G; Hansbro, PM
2020-03-10Nanomedicine advances in cancer therapyHinge, N; Pandey, MM; Singhvi, G; Gupta, G; Mehta, M; Satija, S; Gulati, M; Dureja, H; Dua, K
2021-01-01Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters.Khanuja, HK; Awasthi, R; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Chellappan, DK; Dua, K; Dureja, H
2021-10-01Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases.Hussain, MS; Sharma, P; Dhanjal, DS; Khurana, N; Vyas, M; Sharma, N; Mehta, M; Tambuwala, MM; Satija, S; Sohal, SS; Oliver, BGG; Sharma, HS
2020-01-18Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin ResistanceGupta, G; Wadhwa, R; Pandey, P; Singh, SK; Gulati, M; Satija, S; Mehta, M; Singh, AK; Dureja, H; Collet, T; Pabreja, K; Chellappan, DK; Dua, K
2019-08-01Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseasesMehta, M; Deeksha; Tewari, D; Gupta, G; Awasthi, R; Singh, H; Pandey, P; Chellappan, DK; Wadhwa, R; Collet, T; Hansbro, PM; Kumar, SR; Thangavelu, L; Negi, P; Dua, K; Satija, S
2020-12-01Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative studyPandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K
2020-06-16Oxidative Stress and Immunological Complexities in Multidrug-Resistant TuberculosisWadhwa, R; Sehgal, N; G, N; Aggarwal, T; Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Tambuwala, MM; Oliver, B; Collet, T; Maurya, PK; Hansbro, PM; Dua, K
2020-01-01Oxidative stress in neurology and in neurodegenerative processesGupta, G; Pathak, S; Rawat, S; Mishra, A; Singh, Y; Mehta, M; Satija, S; Khurana, N; De Jesus Andreoli Pinto, T; Shukla, S; Pabreja, K; Chellappan, DK
2020-05Patented therapeutic drug delivery strategies for targeting pulmonary diseases.Thakur, AK; Chellappan, DK; Dua, K; Mehta, M; Satija, S; Singh, I
2021Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy.Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M
2020-08-06Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK
2022-05Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease.Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M
2022-04-25Pharmacological Properties of Bergapten: Mechanistic and Therapeutic AspectsQuetglas-Llabrés, MM; Quispe, C; Herrera-Bravo, J; Catarino, MD; Pereira, OR; Cardoso, SM; Dua, K; Chellappan, DK; Pabreja, K; Satija, S; Mehta, M; Sureda, A; Martorell, M; Satmbekova, D; Yeskaliyeva, B; Sharifi-Rad, J; Rasool, N; Butnariu, M; Bagiu, IC; Bagiu, RV; Calina, D; Cho, WC
2020-08-17Plant-based drug delivery systems in respiratory diseasesMehta, M; Sharma, P; Kaur, S; Dhanjal, DS; Singh, B; Vyas, M; Gupta, G; Chellappan, DK; Nammi, S; Singh, TG; Dua, K; Satija, S; Dua, K; Hansbro, P; Wadhwa, R; Haghi, M; Pont, L; Williams, K
2020-05-04Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.Prasher, P; Sharma, M; Mehta, M; Paudel, KR; Satija, S; Chellappan, DK; Dureja, H; Gupta, G; Tambuwala, MM; Negi, P; Wich, PR; Hansbro, NG; Hansbro, PM; Dua, K